{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:50:50Z","timestamp":1795085450986,"version":"4.10.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["100087\/14\/Z"],"award-info":[{"award-number":["100087\/14\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001275","name":"Oak Foundation","doi-asserted-by":"publisher","award":["OCAY-15-547"],"award-info":[{"award-number":["OCAY-15-547"]}],"id":[{"id":"10.13039\/100001275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Multi-drug resistance (MDR) and extensive-drug resistance (XDR) associated with extended-spectrum beta-lactamases (ESBLs) and carbapenemases in Gram-negative bacteria are global public health concerns. Data on circulating antimicrobial resistance (AMR) genes in Gram-negative bacteria and their correlation with MDR and ESBL phenotypes from Nepal is scarce.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A retrospective study was performed investigating the distribution of ESBL and carbapenemase genes and their potential association with ESBL and MDR phenotypes in <jats:italic>E. coli<\/jats:italic>, <jats:italic>Klebsiella<\/jats:italic> spp., <jats:italic>Enterobacter<\/jats:italic> spp. and <jats:italic>Acinetobacter<\/jats:italic> spp. isolated in a major tertiary hospital in Kathmandu, Nepal, between 2012 and 2018.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>During this period, the hospital isolated 719 <jats:italic>E. coli<\/jats:italic>, 532 <jats:italic>Klebsiella<\/jats:italic> spp., 520 <jats:italic>Enterobacter<\/jats:italic> spp. and 382 <jats:italic>Acinetobacter<\/jats:italic> spp.; 1955\/2153 (90.1%) of isolates were MDR and half (1080\/2153) were ESBL producers. Upon PCR amplification, <jats:italic>bla<\/jats:italic><jats:sub>TEM<\/jats:sub> (1281\/1771; 72%), <jats:italic>bla<\/jats:italic><jats:sub>CTXM-1<\/jats:sub> (930\/1771; 53%) and <jats:italic>bla<\/jats:italic><jats:sub>CTXM-8<\/jats:sub> (419\/1771; 24%) were the most prevalent ESBL genes in the enteric bacilli. <jats:italic>Bla<\/jats:italic><jats:sub>OXA<\/jats:sub> and <jats:italic>bla<\/jats:italic><jats:sub>OXA-51<\/jats:sub> were the most common <jats:italic>bla<\/jats:italic><jats:sub>OXA<\/jats:sub> family genes in the enteric bacilli (918\/1771; 25%) and <jats:italic>Acinetobacter<\/jats:italic> spp. (218\/382; 57%) respectively. Sixteen percent (342\/2153) of all isolates and 20% (357\/1771) of enteric bacilli harboured <jats:italic>bla<\/jats:italic><jats:sub>NDM-1<\/jats:sub> and <jats:italic>bla<\/jats:italic><jats:sub>KPC<\/jats:sub> carbapenemase genes respectively. Of enteric bacilli, <jats:italic>Enterobacter<\/jats:italic> spp. was the most frequently positive for <jats:italic>bla<\/jats:italic><jats:sub>KPC<\/jats:sub> gene (201\/337; 60%). The presence of each <jats:italic>bla<\/jats:italic><jats:sub>CTX-M<\/jats:sub> and <jats:italic>bla<\/jats:italic><jats:sub>OXA<\/jats:sub> were significantly associated with non-susceptibility to third generation cephalosporins (OR 14.7, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 and OR 2.3, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05, respectively).The presence of each <jats:italic>bla<\/jats:italic><jats:sub>TEM<\/jats:sub>, <jats:italic>bla<\/jats:italic><jats:sub>CTXM<\/jats:sub> and <jats:italic>bla<\/jats:italic><jats:sub>OXA<\/jats:sub> family genes were significantly associated with ESBL positivity (OR 2.96, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001; OR 14.2, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 and OR 1.3, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05 respectively) and being MDR (OR 1.96, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001; OR 5.9, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 and OR 2.3, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001 respectively).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>This study documents an alarming level of AMR with high prevalence of MDR ESBL- and carbapenemase-positive ESKAPE microorganisms in our clinical setting. These data suggest a scenario where the clinical management of infected patients is increasingly difficult and requires the use of last-resort antimicrobials, which in turn is likely to intensify the magnitude of global AMR crisis.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12941-020-00390-y","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T06:02:54Z","timestamp":1603260174000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["A high prevalence of multi-drug resistant Gram-negative bacilli in a Nepali tertiary care hospital and associated widespread distribution of Extended-Spectrum Beta-Lactamase (ESBL) and carbapenemase-encoding genes"],"prefix":"10.1186","volume":"19","author":[{"given":"Sulochana","family":"Manandhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael M.","family":"Zellweger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhukesh","family":"Maharjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Dongol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna G.","family":"Prajapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"Thwaites","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buddha","family":"Basnyat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer Mani","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5179-650X","authenticated-orcid":false,"given":"Abhilasha","family":"Karkey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"issue":"8","key":"390_CR1","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1086\/533452","volume":"197","author":"LB Rice","year":"2008","unstructured":"Rice LB. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J Infect Dis. 2008;197(8):1079\u201381.","journal-title":"J Infect Dis"},{"key":"390_CR2","first-page":"5","volume":"12","author":"M Exner","year":"2017","unstructured":"Exner M, Bhattacharya S, Christiansen B, Gebel J, Goroncy-Bermes P, Hartemann P, et al. Antibiotic resistance: What is so special about multidrug-resistant Gram-negative bacteria? GMS Hyg Infect Control. 2017;12:5.","journal-title":"GMS Hyg Infect Control."},{"key":"390_CR3","first-page":"7","volume":"1","author":"World Health Organisation","year":"2014","unstructured":"World Health Organisation. Global report on surveillance: antimicrobial resistance. World Heal Organ. 2014;1:7.","journal-title":"World Heal Organ."},{"issue":"2","key":"390_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3904\/kjim.2012.27.2.128","volume":"27","author":"DM Livermore","year":"2012","unstructured":"Livermore DM. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med. 2012;27(2):128.","journal-title":"Korean J Intern Med"},{"issue":"1","key":"390_CR5","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1093\/cid\/ciw829","volume":"64","author":"Y Doi","year":"2017","unstructured":"Doi Y, Bonomo RA, Hooper DC, Kaye KS, Johnson JR, Clancy CJ, et al. Gram-negative bacterial infections: research priorities, accomplishments, and future directions of the antibacterial resistance leadership group. Clin Infect Dis. 2017;64(1):S30-5.","journal-title":"Clin Infect Dis."},{"issue":"3","key":"390_CR6","doi-asserted-by":"publisher","first-page":"e1001974","DOI":"10.1371\/journal.pmed.1001974","volume":"13","author":"R Laxminarayan","year":"2016","unstructured":"Laxminarayan R, Chaudhury RR. Antibiotic resistance in india: drivers and opportunities for action. PLOS Med. 2016;13(3):e1001974.","journal-title":"PLOS Med"},{"issue":"5","key":"390_CR7","first-page":"482","volume":"132","author":"R Bhatia","year":"2010","unstructured":"Bhatia R, Narain JP. The growing challenge of antimicrobial resistance in the South-East Asia Region\u2013are we losing the battle? Indian J Med Res. 2010;132(5):482\u20136.","journal-title":"Indian J Med Res"},{"issue":"4","key":"390_CR8","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","volume":"18","author":"DL Paterson","year":"2005","unstructured":"Paterson DL, Bonomo RA. Extended-spectrum \u03b2-lactamases: a clinical update. Clin Microbiol Rev. 2005;18(4):657\u201386.","journal-title":"Clin Microbiol Rev."},{"issue":"3","key":"390_CR9","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1128\/CMR.00116-14","volume":"28","author":"AJ Mathers","year":"2015","unstructured":"Mathers AJ, Peirano G, Pitout JDD. The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev. 2015;28(3):565\u201391.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"390_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","volume":"8","author":"JDD Pitout","year":"2008","unstructured":"Pitout JDD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8(3):159\u201366.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"390_CR11","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1128\/CMR.14.4.933-951.2001","volume":"14","author":"PA Bradford","year":"2001","unstructured":"Bradford PA. Extended-spectrum \u03b2-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001;14(4):933\u201351.","journal-title":"Clin Microbiol Rev"},{"key":"390_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13756-015-0059-2","volume":"4","author":"S Ansari","year":"2015","unstructured":"Ansari S, Hari P, Gautam R, Shrestha S, Neopane P, Rimal B, Mandal F, Ansari SR, Chapagain ML, Ansari SRS, Nepal HP, Gautam R, Shrestha S, Neopane P, et al. Community acquired multi-drug resistant clinical isolates of Escherichia coli in a tertiary care center of Nepal. Antimicrob Resist Infect Control. 2015;4:15.","journal-title":"Antimicrob Resist Infect Control."},{"key":"390_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13756-015-0085-0","volume":"4","author":"KK Yadav","year":"2015","unstructured":"Yadav KK, Adhikari N, Khadka R, Pant AD, Shah B. Multidrug resistant Enterobacteriaceae and extended-spectrum \u03b2-lactamase producing Escherichia coli: a cross-sectional study in National Kidney Center. Nepal Antimicrob Resist Infect Control. 2015;4:42.","journal-title":"Nepal Antimicrob Resist Infect Control"},{"issue":"1","key":"390_CR14","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1186\/1756-0500-7-694","volume":"7","author":"R Pokhrel","year":"2014","unstructured":"Pokhrel R, Thapa B, Kafle R, Shah P, Tribuddharat C. Co-existence of beta-lactamases in clinical isolates of Escherichia coli from Kathmandu. Nepal BMC Res Notes. 2014;7(1):694.","journal-title":"Nepal BMC Res Notes"},{"key":"390_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/847569","volume":"2013","author":"S Khanal","year":"2013","unstructured":"Khanal S, Joshi DR, Bhatta DR, Devkota U, Pokhrel BM. \u03b2-Lactamase-producing multidrug-resistant bacterial pathogens from tracheal aspirates of intensive care unit patients at national institute of neurological and allied sciences. Nepal ISRN Microbiol. 2013;2013:1\u20135.","journal-title":"Nepal ISRN Microbiol"},{"key":"390_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/572163","volume":"2015","author":"P Bhandari","year":"2015","unstructured":"Bhandari P, Thapa G, Pokhrel BM, Bhatta DR, Devkota U. Nosocomial isolates and their drug resistant pattern in icu patients at national institute of neurological and allied sciences. Nepal Int J Microbiol. 2015;2015:1\u20136.","journal-title":"Nepal Int J Microbiol"},{"issue":"10","key":"390_CR17","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1089\/mdr.2018.0063","volume":"24","author":"ER Khan","year":"2018","unstructured":"Khan ER, Aung MS, Paul SK, Ahmed S, Haque N, Ahamed F, et al. Prevalence and molecular epidemiology of clinical isolates of escherichia coli and klebsiella pneumoniae harboring extended-spectrum beta-lactamase and carbapenemase genes in Bangladesh. Microb Drug Resist. 2018;24(10):1568\u201379.","journal-title":"Microb Drug Resist"},{"issue":"7","key":"390_CR18","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13756-018-0309-1","volume":"20","author":"S Abrar","year":"2018","unstructured":"Abrar S, Hussain S, Khan RA, Ul Ain N, Haider H, Riaz S. Prevalence of extended-spectrum-\u03b2-lactamase-producing Enterobacteriaceae: first systematic meta-analysis report from Pakistan. Antimicrob Resist Infect Control. 2018;20(7):26.","journal-title":"Antimicrob Resist Infect Control"},{"key":"390_CR19","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.1136\/bmj.k5314","volume":"364","author":"S Chaurasia","year":"2019","unstructured":"Chaurasia S, Sivanandan S, Agarwal R, Ellis S, Sharland M, Sankar MJ. Neonatal sepsis in South Asia: huge burden and spiralling antimicrobial resistance. BMJ. 2019;364:5314.","journal-title":"BMJ."},{"key":"390_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/ajcp\/45.4_ts.493","volume":"45","author":"A Bauer","year":"1966","unstructured":"Bauer A, Kirby W, Sherris J, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966;45:493\u20136.","journal-title":"Am J Clin Pathol"},{"key":"390_CR21","first-page":"1","volume-title":"Standards for antimicrobial susceptibility testing; twenty-fourth informational supplement, CLSI document M100\u2013S24","author":"Clinical and Laboratory Standards Institute","year":"2014","unstructured":"Clinical and Laboratory Standards Institute. Standards for antimicrobial susceptibility testing; twenty-fourth informational supplement, CLSI document M100\u2013S24. New York: Clinical and Laboratory Standards Institute; 2014. p. 1\u2013226."},{"issue":"9","key":"390_CR22","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1128\/AAC.36.9.1877","volume":"36","author":"KS Thomson","year":"1992","unstructured":"Thomson KS, Sanders CC. Detection of extended-spectrum \u03b2-lactamases in members of the family Enterobacteriaceae: comparison of the double-disk and three-dimensional tests. Antimicrob Agents Chemother. 1992;36(9):1877\u201382.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"390_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1093\/jac\/dki412","volume":"57","author":"N Woodford","year":"2006","unstructured":"Woodford N, Fagan EJ, Ellington MJ. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum \u03b2-lactamases. J Antimicrob Chemother. 2006;57(1):154\u20135.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"390_CR24","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","volume":"70","author":"L Poirel","year":"2011","unstructured":"Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119\u201323.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"390_CR25","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1128\/JCM.01773-10","volume":"49","author":"P Nordmann","year":"2011","unstructured":"Nordmann P, Poirel L, Carr\u00ebr A, Toleman MA, Walsh TR. How to detect NDM-1 producers. J Clin Microbiol. 2011;49(2):718\u201321.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"390_CR26","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ijantimicag.2006.01.004","volume":"27","author":"N Woodford","year":"2006","unstructured":"Woodford N, Ellington MJ, Coelho JM, Turton JF, Ward ME, Brown S, et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agents. 2006;27(4):351\u20133.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"390_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4103\/2277-9175.186986","volume":"5","author":"K Shirani","year":"2016","unstructured":"Shirani K, Ataei B, Roshandel F. Antibiotic resistance pattern and evaluation of metallo-beta lactamase genes (VIM and IMP) in Pseudomonas aeruginosa strains producing MBL enzyme, isolated from patients with secondary immunodeficiency. Adv Biomed Res. 2016;5(1):124.","journal-title":"Adv Biomed Res"},{"issue":"12","key":"390_CR28","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1109\/TVCG.2014.2346248","volume":"20","author":"A Lex","year":"2014","unstructured":"Lex A, Gehlenborg N, Strobelt H, Vuillemot R, Pfister H. UpSet: visualization of intersecting sets. IEEE Trans Vis Comput Graph. 2014;20(12):1983\u201392.","journal-title":"IEEE Trans Vis Comput Graph"},{"issue":"1","key":"390_CR29","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1756-0500-6-98","volume":"6","author":"S Mishra","year":"2013","unstructured":"Mishra S, Rijal B, Pokhrel B. Emerging threat of multidrug resistant bugs\u2014Acinetobacter calcoaceticus baumannii complex and Methicillin resistant Staphylococcus aureus. BMC Res Notes. 2013;6(1):98.","journal-title":"BMC Res Notes"},{"issue":"2","key":"390_CR30","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4103\/ijmr.IJMR_172_18","volume":"149","author":"V Gautam","year":"2019","unstructured":"Gautam V, Thakur A, Sharma M, Singh A, Bansal S, Sharma A, et al. Molecular characterization of extended-spectrum \u03b2-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: a multi-centric study from tertiary care hospitals in India. Indian J Med Res. 2019;149(2):208\u201315.","journal-title":"Indian J Med Res"},{"issue":"3","key":"390_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.4103\/ijabmr.IJABMR_28_16","volume":"7","author":"M Jobayer","year":"2017","unstructured":"Jobayer M, Afroz Z, Nahar S, Begum A, Begum S, Shamsuzzaman S. Antimicrobial susceptibility pattern of extended-spectrum beta-lactamases producing organisms isolated in a Tertiary Care Hospital, Bangladesh. Int J Appl Basic Med Res. 2017;7(3):189\u201392.","journal-title":"Int J Appl Basic Med Res"},{"issue":"10","key":"390_CR32","first-page":"1888","volume":"19","author":"M Licker","year":"2015","unstructured":"Licker M, Anghel A, Moldovan R, Hogea E, Muntean D, Horhat F, et al. Genotype-phenotype correlation in multiresistant Escherichia coli and Klebsiella pneumoniae strains isolated in Western Romania. Eur Rev Med Pharmacol Sci. 2015;19(10):1888\u201394.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"390_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13756-017-0180-5","volume":"6","author":"PR Joshi","year":"2017","unstructured":"Joshi PR, Acharya M, Kakshapati T, Leungtongkam U, Thummeepak R, Sitthisak S. Co-existence of bla OXA-23 and bla NDM-1 genes of Acinetobacter baumannii isolated from Nepal: antimicrobial resistance and clinical significance. Antimicrob Resist Infect Control. 2017;6(1):21.","journal-title":"Antimicrob Resist Infect Control"},{"issue":"2","key":"390_CR34","doi-asserted-by":"publisher","first-page":"240","DOI":"10.4103\/ijmr.IJMR_2085_17","volume":"149","author":"S Vijayakumar","year":"2019","unstructured":"Vijayakumar S, Mathur P, Kapil A, Das BK, Ray P, Gautam V, et al. Molecular characterization & epidemiology of carbapenem-resistant Acinetobacter baumannii collected across India. Indian J Med Res. 2019;149(2):240\u20136.","journal-title":"Indian J Med Res"},{"issue":"2","key":"390_CR35","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3329\/bmrcb.v41i2.29991","volume":"41","author":"MN Khatun","year":"2015","unstructured":"Khatun MN, Farzana R, Lopes BS, Shamsuzzaman SM. Molecular characterization and resistance profile of nosocomial Acinetobacter baumannii intensive care unit of tertiary care hospital in Bangladesh. Bangladesh Med Res Counc Bull. 2015;41(2):101\u20137.","journal-title":"Bangladesh Med Res Counc Bull"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-020-00390-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-020-00390-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-020-00390-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T23:33:59Z","timestamp":1634772839000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-020-00390-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["390"],"URL":"https:\/\/doi.org\/10.1186\/s12941-020-00390-y","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]},"assertion":[{"value":"26 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An ethical approval for conducting this study was taken from Nepal Health Research Council (NHRC) (Reference number 1017). Data used in this retrospective study were the anonymised routine microbiology laboratory results originating from Patan Hospital. These data were devoid of any patients\u2019 identifying information. Further, the data used in this study were a part of routine surveillance for infection prevention and control at Patan Hospital. Thus, individual written informed consent was not required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All data used in this study were the anonymised microbiological data devoid of patients\u2019 identification and personal information. Thus obtaining consent for publication is not applicable for this study. All authors consented for the publication of this research.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}